Evidence map›Paper›PMID 25912399›Full record

ArticleNature communications2015

Heparanase is a host enzyme required for herpes simplex virus-1 release from cells.

Satvik R Hadigal, Alex M Agelidis, Ghadah A Karasneh, Thessicar E Antoine, Abraam M Yakoub, Vishnu C Ramani, Ali R Djalilian, Ralph D Sanderson, Deepak Shukla

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 1 synthesis or guideline pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Microorganisms · 2025
    Review
  8. Oral SARS-CoV-2 Infection and Risk for Long Covid.Reviews in medical virology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Satvik R HadigalOcular Virology Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1855 West Taylor Street, M/C 648, Chicago, Illinois 60612, USA.
Alex M Agelidis1] Ocular Virology Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1855 West Taylor Street, M/C 648, Chicago, Illinois 60612, USA [2] Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, E-704 Medical Sciences Building, M/C 790, 835 South Wolcott Avenue, Chicago, Illinois 60612, USA.
Ghadah A Karasneh1] Ocular Virology Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1855 West Taylor Street, M/C 648, Chicago, Illinois 60612, USA [2] Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, E-704 Medical Sciences Building, M/C 790, 835 South Wolcott Avenue, Chicago, Illinois 60612, USA.
Thessicar E Antoine1] Ocular Virology Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1855 West Taylor Street, M/C 648, Chicago, Illinois 60612, USA [2] Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, E-704 Medical Sciences Building, M/C 790, 835 South Wolcott Avenue, Chicago, Illinois 60612, USA.
Abraam M Yakoub1] Ocular Virology Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1855 West Taylor Street, M/C 648, Chicago, Illinois 60612, USA [2] Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, E-704 Medical Sciences Building, M/C 790, 835 South Wolcott Avenue, Chicago, Illinois 60612, USA.
Vishnu C RamaniDepartment of Pathology, University of Alabama at Birmingham, 1720 2nd Avenue South, Birmingham, Alabama 35294, USA.
Ali R DjalilianOcular Virology Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1855 West Taylor Street, M/C 648, Chicago, Illinois 60612, USA.
Ralph D SandersonDepartment of Pathology, University of Alabama at Birmingham, 1720 2nd Avenue South, Birmingham, Alabama 35294, USA.
Deepak Shukla1] Ocular Virology Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1855 West Taylor Street, M/C 648, Chicago, Illinois 60612, USA [2] Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, E-704 Medical Sciences Building, M/C 790, 835 South Wolcott Avenue, Chicago, Illinois 60612, USA.
University of Illinois Chicago · USUniversity of Alabama at Birmingham · US

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHUKLA, DEEPAK · 1985 to 2025
$14.8M
Heparanase Regulation of Myeloma Metastasis: Mechanism and TherapyR01CA138340 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SANDERSON, RALPH D · 2009 to 2018
$3.3M
Significance of heparan sulfate in HSV-1 spreadK02AI081869 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHUKLA, DEEPAK · 2009 to 2013
$531k
Micro-nano Platforms for HSV VaccineR21AI103754 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHUKLA, DEEPAK · 2013 to 2014
$439k
Role of Optineurin in Ocular Herpes InfectionR21EY023058 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHUKLA, DEEPAK · 2013 to 2014
$435k
NCI NIH HHS CA138340NCI NIH HHS R01 CA138340NEI NIH HHS EY001792NEI NIH HHS EY023058NEI NIH HHS P30 EY001792NEI NIH HHS R21 EY023058NIAID NIH HHS AI081869NIAID NIH HHS AI103754NIAID NIH HHS K02 AI081869NIAID NIH HHS R21 AI103754
6 · The paper itself

Abstract

Herpesviruses exemplified by herpes simplex virus-1 (HSV-1) attach to cell surface heparan sulfate (HS) for entry into host cells. However, during a productive infection, the HS moieties on parent cells can trap newly exiting viral progenies and inhibit their release. Here we demonstrate that a HS-degrading enzyme of the host, heparanase (HPSE), is upregulated through NF-kB and translocated to the cell surface upon HSV-1 infection for the removal of HS to facilitate viral release. We also find a significant increase in HPSE release in vivo during infection of murine corneas and that knockdown of HPSE in vivo inhibits virus shedding. Overall, we propose that HPSE acts as a molecular switch for turning a virus-permissive 'attachment mode' of host cells to a virus-deterring 'detachment mode'. Since many human viruses use HS as an attachment receptor, the HPSE-HS interplay may delineate a common mechanism for virus release.

Indexed as

AnimalsChlorocebus aethiopsFemaleGlucuronidaseHEK293 CellsHeLa CellsHeparanaseHeparan SulfateHerpes SimplexHerpesvirus 1, HumanHost-Pathogen InteractionsHumansMiceMice, Inbred BALB CUp-RegulationVero CellsGlucuronidaseHeparanaseHeparan Sulfate

Identifiers

PMID25912399
PMCPMC4413471
OpenAlexW2030471534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.